Dementia and Cognitive Impairment

Dementia and Cognitive Impairment

Dementia and Cognitive Impairment

On this page

Definitions & Overview - Mind Fades

  • Dementia: Chronic, progressive, global cognitive decline; consciousness clear; ADLs impaired.
  • Delirium: Acute, fluctuating attention deficit; altered consciousness; ADLs often impaired. 📌 I WATCH DEATH (Infection, Withdrawal, Acute metabolic, Trauma, CNS pathology, Hypoxia, Deficiencies, Endocrinopathies, Acute vascular, Toxins/drugs, Heavy metals).
  • Mild Cognitive Impairment (MCI): Cognitive decline greater than normal for age/education; ADLs intact; not dementia.
  • Key Differentiating Features:
FeatureDementiaDeliriumMCI
OnsetInsidiousAcuteInsidious
CourseProgressiveFluctuatingStable/Progressive
ConsciousnessClearAlteredClear
AttentionNormal initiallyImpairedNormal
ADLsImpairedOften ImpairedIntact
FeatureAlzheimer's Disease (AD)Vascular Dementia (VaD)Lewy Body Dementia (LBD)Frontotemporal Dementia (FTD) (Pick's Disease)
OnsetInsidious, gradualVariable (sudden/stepwise/gradual)GradualGradual, often < 65 yrs
CourseProgressiveStepwise or progressiveFluctuating, progressiveProgressive
Key Cognitive DeficitsAmnesia (early), aphasia, apraxia, agnosiaExecutive dysfunction, focal deficits (site-dependent)Fluctuating attention, visual hallucinations, visuospatial impairmentBehavioural (disinhibition, apathy) or language variants (e.g., PPA)
Motor FeaturesMinimal early; late rigidityFocal neurological signs, gait issuesParkinsonism (often early, symmetric), REM sleep behaviour disorder (RBD)+/- Parkinsonism, MND signs (some variants)
Pathology/Signsβ-amyloid plaques, Tau neurofibrillary tanglesCerebrovascular lesions (infarcts, lacunes, white matter)α-synuclein Lewy bodies (cortical/subcortical), Lewy neurites. 📌 LBD: Fluctuations, Hallucinations (visual), ParkinsonismTau (Pick bodies) or TDP-43 inclusions; marked frontal/temporal atrophy

Clinical Approach & Workup - The Cognitive Quest

  • History: Collateral history is crucial. Obtain from family/caregivers.
  • Neurological Exam: Key elements: focal deficits, gait changes, primitive reflexes.
  • Cognitive Screening Tools:
    • MMSE: Score < 24/30 suggests impairment.
    • MoCA: Score < 26/30; more sensitive for Mild Cognitive Impairment (MCI).
    • Clock Drawing Test (CDT): Assesses visuospatial and executive functions.
  • Laboratory Workup (for reversible causes): Thyroid function (TSH), Vitamin B12, CBC, CMP.
    • 📌 Mnemonic for reversible causes: DEMENTIAS (Drugs, Emotional disorders, Metabolic, Endocrine, Nutritional, Trauma, Infection, Alcohol/Arteriosclerosis, Subdural hematoma).
  • Neuroimaging:
    • CT/MRI: Indications: acute onset, age <60, focal neurological signs, suspected NPH. Typical AD: hippocampal atrophy.
    • PET: Role in differentiating dementias (FDG-PET for metabolic patterns); amyloid/tau PET for specific proteinopathies.

⭐ CSF analysis for ↓ amyloid beta 42 (A$\beta$42) and ↑ tau protein (total & phosphorylated) can support Alzheimer's Disease (AD) diagnosis, particularly in atypical presentations.

Management Strategies - Navigating the Maze

  • Non-Pharmacological Interventions (First-line):

    • Cognitive stimulation, regular physical activity.
    • Environmental modifications (e.g., safety, orientation aids).
    • Caregiver education and strong support.
  • Pharmacological Treatment:

    Drug ClassExamplesPrimary IndicationCommon DosesKey Side Effects
    Cholinesterase InhibitorsDonepezil, Rivastigmine, GalantamineMild-Moderate AD, LBDDonepezil: 5-10 mg/day; Rivastigmine: 3-12 mg/day; Galantamine: 8-24 mg/dayGI upset (nausea, diarrhea), bradycardia, insomnia
    NMDA Receptor AntagonistMemantineModerate-Severe AD (adjunct or mono)Start 5 mg/day, target 20 mg/day (10 mg BID)Dizziness, headache, confusion, agitation, constipation
  • Behavioral & Psychological Symptoms of Dementia (BPSD):

    • Non-pharmacological strategies first.
    • Judicious psychotropics for severe/refractory symptoms.

⭐ Cholinesterase inhibitors often show better efficacy in Lewy Body Dementia (LBD) for cognitive and neuropsychiatric symptoms than in Frontotemporal Dementia (FTD).

High‑Yield Points - ⚡ Biggest Takeaways

  • Alzheimer's Disease (AD): Most common; amyloid plaques, tau tangles, progressive memory loss.
  • Vascular Dementia: Stepwise decline in cognition; associated with CVD risk factors and stroke history.
  • Lewy Body Dementia (LBD): Visual hallucinations, parkinsonism, fluctuating cognition; REM sleep behavior disorder is a key early sign.
  • Frontotemporal Dementia (FTD): Early personality changes, disinhibition, or progressive aphasia.
  • Always rule out reversible causes: B12 deficiency, hypothyroidism, Normal Pressure Hydrocephalus.
  • MMSE < 24 suggests impairment; cholinesterase inhibitors (e.g., Donepezil) are used for AD treatment.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Dementia and Cognitive Impairment

Test your understanding with these related questions

Reversible dementia causes are all except-

1 of 5

Flashcards: Dementia and Cognitive Impairment

1/7

_____ delirium is commonly associated with hepatic and renal encephalopathies.

TAP TO REVEAL ANSWER

_____ delirium is commonly associated with hepatic and renal encephalopathies.

Hypoactive

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Dementia and Cognitive Impairment - Free Indian Medical PG